Optometry Times
CONTINUE TO SITE >

OR WAIT 15 SECS

Optometry Times
Spotlight
Clinical
News
Media
Conferences
Blog
Publications
Resources
Subscribe

  • Advertise
  • About Us
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
  • MJHLS Brand Logo

© 2021 MJH Life Sciences and Optometry Times. All rights reserved.

Spotlight
  • Contact Lens Update
  • Diabetic Eye Disease
  • Branded vs Generics
  • Glaucoma Management
  • Vision Innovation
  • Dry Eye Viewpoint
  • Diabetic Eye Disease Viewpoint
  • Myopia Management
ClinicalSee All >
  • Allergy
  • Cataract
  • Contact Lenses
  • COVID-19
  • Dry Eye
  • Glaucoma
  • LASIK
  • OCT
  • Refractive Surgery
  • Retina
  • Advertise
  • About Us
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Optometry Times. All rights reserved.

Advancements in dry eye managment

Introduction and overview

Consequences and epidemiology of untreated dry eye

Diagnosis and overlooking asymptomatic patients with DED

Standard testing and assessment for DED

General Principles of Treatment of DED

OD and MD communication for optimal care

Review of artificial tears for DED

Corticosteroids and Immunomodulators for the treatment of dry eye

The role of nutritional supplements and antibiotics in DED

How to treat meibomian gland dysfunction

In-office procedures and patient resistance for DED treatments

Treatments for aqueous dry eye

Challenges in the management of DED

Counseling and formulary concerns for DED therapies

Overlapping diseases and COVID-19's impact

Agents in the pipeline for DED

Novel agents in the pipeline for DED